Xcovery Holdingsincis A Biopharmaceutical Company Based In Miamifloridadedicated To Advancing Cancer Treatmentthe Company Specializes In The Research And Development Of Small Moleculesparticularly Next Generation Tyrosine Kinase Inhibitorstkis Aimed At Improving Patient Outcomes In Oncology Xcovery S Innovative Approach Focuses On Creating Tkis That Offer Enhanced Efficacy And Reduced Toxicitythese Treatments Can Be Used Alone Or In Combination With Other Agents To Effectively Combat Treatment Resistance In Cancernotable Products In Development Include Ensartiniban Alk Inhibitor For Alk Positive Non Small Cell Lung Cancerand Vorolaniba Multi Kinase Inhibitor Designed To Work Alongside Other Compounds To Improve Clinical Benefits The Company Has Also Formed Strategic Partnershipsincluding A Majority Stake Acquisition In Meryx Pharmaceuticalsto Further Its Mission Of Developing Small Molecule Oncology Drugs On A Global Scale
No conferences found for this company.
| Company Name | Xcovery Holding Co Llc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
